Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study

BACKGROUND: COVID-19 convalescent plasma (CCP) contains neutralising anti-SARS-CoV-2 antibodies that may be useful as COVID-19 passive immunotherapy in patients at risk of developing severe disease. Such plasma from convalescent patients may also have additional immune-modulatory properties when tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Cognasse, Fabrice, Hamzeh-Cognasse, Hind, Rosa, Mickael, Corseaux, Delphine, Bonneaudeau, Brigitte, Pierre, Chloe, Huet, Julie, Arthaud, Charles Antoine, Eyraud, Marie Ange, Prier, Amélie, Duchez, Anne Claire, Ebermeyer, Theo, Heestermans, Marco, Audoux-Caire, Estelle, Philippot, Quentin, Le Voyer, Tom, Hequet, Olivier, Fillet, Anne-Marie, Chavarin, Patricia, Legrand, Dominique, Richard, Pascale, Pirenne, France, Gallian, Pierre, Casanova, Jean Laurent, Susen, Sophie, Morel, Pascal, Lacombe, Karine, Bastard, Paul, Tiberghien, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758484/
https://www.ncbi.nlm.nih.gov/pubmed/36535107
http://dx.doi.org/10.1016/j.ebiom.2022.104414

Ejemplares similares

Ejemplares similares